Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2024
Aptorum Group Limited (NASDAQ: APM) (Aptorum Group or the Company), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious...
Business Wire·9mo ago
More News
Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update
Aptorum Group Limited (Nasdaq: APM) (Aptorum Group or We), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious...
Business Wire·1y ago
Aptorum Group Ltd trading halted, volatility trading pause
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
Aptorum Group Ltd trading resumes
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
12 acciones de salud en movimiento en la sesi n intrad a del 06/03/2024
Acciones al alza
Aptorum Gr (NASDAQ:APM) experimentaron un repunte del 680,24% para establecerse en los 11,31 d lares durante la sesi n del regular del mi rcoles.
NKGen Biotech (NASDAQ:NKGN...
Benzinga·2y ago
BeyondSpring, enVVeno Medical, Aptorum Group among healthcare movers
BeyondSpring, enVVeno Medical, Aptorum Group among healthcare movers...
SeekingAlpha.com: All News·2y ago
Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy Business
Aptorum Group Limited (Nasdaq: APM), a clinical stage biopharmaceutical company (Aptorum), and privately-held YOOV Group Holding Ltd. (YOOV) jointly announced today that they entered into an...